Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Angiodynamics (ANGO) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to $41.5 million.

  • Angiodynamics' Shares Outstanding (Weighted Average) rose 151.51% to $41.5 million in Q4 2025 from the same period last year, while for Nov 2025 it was $41.5 million, marking a year-over-year increase of 151.51%. This contributed to the annual value of $40.9 million for FY2025, which is 167.24% up from last year.
  • As of Q4 2025, Angiodynamics' Shares Outstanding (Weighted Average) stood at $41.5 million, which was up 151.51% from $41.2 million recorded in Q3 2025.
  • Angiodynamics' 5-year Shares Outstanding (Weighted Average) high stood at $41.5 million for Q4 2025, and its period low was $38.3 million during Q2 2021.
  • Moreover, its 5-year median value for Shares Outstanding (Weighted Average) was $39.7 million (2023), whereas its average is $39.8 million.
  • As far as peak fluctuations go, Angiodynamics' Shares Outstanding (Weighted Average) skyrocketed by 95.0% in 2021, and later soared by 203.55% in 2024.
  • Over the past 5 years, Angiodynamics' Shares Outstanding (Weighted Average) (Quarter) stood at $39.1 million in 2021, then grew by 1.12% to $39.5 million in 2022, then grew by 1.85% to $40.2 million in 2023, then rose by 1.75% to $40.9 million in 2024, then grew by 1.52% to $41.5 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $41.5 million for Q4 2025, versus $41.2 million for Q3 2025 and $40.9 million for Q2 2025.